Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Synairgen Share Price
  4. Synairgen Share Regulatory News
  5. Change of NOMAD

Pin to quick picksSynairgen Regulatory News (SNG)

Synairgen Information

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.00
Bid: 6.76
Ask: 7.50
Change: 1.24 (21.53%)
Spread: 0.74 (10.947%)
Open: 5.72
High: 7.22
Low: 5.72
Prev. Close: 5.76
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change of NOMAD

7 Nov 2008 15:25

RNS Number : 7410H
Synairgen plc
07 November 2008
 



7 November 2008

Synairgen plc

Change of NOMAD

Synairgen plc announces that in accordance with AIM Rule 17, the Company's nominated adviser and broker is Teathers, a division of Straumur-Burdaras Investment Bank hf., of Berkeley Square House,

Third Floor, Berkeley Square, London W1J 6BU

Ends

Enquiries:

Synairgen plc

John Ward   +44 2380 512 800 

 

Teathers Limited +44 20 7426 9000

Shaun Dobson, Managing Director 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPUUGPPGUPRGAM
12345678910
Date   Source Headline
13th Nov 200812:15 pmRNSResult of AGM
7th Nov 20083:25 pmRNSChange of NOMAD
31st Oct 20089:00 amRNSTotal Voting Rights
20th Oct 20087:00 amRNSDirector/PDMR Shareholding and Additional Listing
10th Oct 20081:53 pmRNSPosting of 2008 Annual Report
8th Oct 20089:12 amRNSChange of Adviser Name
22nd Sep 20087:00 amRNSResearch Update
4th Aug 200810:00 amRNSDirector/PDMR Shareholding
31st Jul 20087:00 amRNSFinal Results
29th Jul 20087:00 amRNSCommencement of Clinical Tria
14th Jul 200811:48 amRNSNotice of Results
23rd May 20087:00 amRNSPresentation of data at ATS
13th Mar 20087:01 amRNSDirector Shareholding
12th Mar 20087:01 amRNSInterim Results
25th Feb 20087:01 amRNSNotice of Results
11th Feb 20087:01 amRNSPatent Granted
15th Nov 20077:01 amRNSResult of AGM
12th Nov 20078:25 amRNSContract with Alpha Biologics
31st Oct 200712:45 pmRNSDirector/PDMR Shareholding
28th Sep 20077:04 amRNSLicence/ Supply by Rentschler
26th Sep 20077:01 amRNSFinal Results
20th Aug 20077:00 amRNSNotice of Preliminary Results
17th Aug 20071:52 pmRNSAIM Rule 26
16th Aug 20072:54 pmRNSChange of Adviser
28th Jun 20072:30 pmRNSDirector/PDMR Shareholding
12th Jun 20077:02 amRNSResearch Update
20th Mar 20074:12 pmRNSHolding(s) in Company
19th Mar 20077:01 amRNSInterim Results
23rd Feb 20073:16 pmRNSHolding(s) in Company
13th Feb 20074:40 pmRNSNotice of Results
12th Dec 200611:55 amRNSTotal Voting Rights
30th Nov 20063:18 pmRNSDirector/PDMR Shareholding
15th Nov 20067:02 amRNSLicenses novel Peptide
8th Nov 200611:11 amRNSHolding(s) in Company
8th Nov 200610:21 amRNSDirector/PDMR Shareholding
18th Sep 20067:01 amRNSFinal Results
1st Sep 20067:00 amRNSNotice of Results
14th Aug 20067:04 amRNSLicensing Deal
14th Aug 20067:01 amRNSLicensing Agreement
24th May 20067:01 amRNSResearch Update
11th Apr 200612:56 pmRNSDirectorate Change
23rd Feb 20067:01 amRNSInterim Results
16th Jan 200611:00 amRNSNotice of Results
16th Nov 20053:40 pmRNSDirector/PDMR Shareholding
15th Nov 200512:15 pmRNSResult of AGM
15th Nov 20057:02 amRNSInterferon-Beta Enters Clinic
14th Nov 20057:00 amRNSChange of Adviser
27th Sep 20057:01 amRNSFinal Results
6th Sep 20059:00 amRNSNotice of Results
13th Jul 200511:18 amRNSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.